Research graph
References from Metabolic effects of moxonidine and other centrally acting antihypertensives. Local targets link to admitted publications; unresolved targets remain external evidence.
Use of centrally acting sympatholytic agents in the management of hypertension
10.1001/archinte.1991.00400080122024 · 1991 · External reference
10.1097/00004872-199715020-00001
10.1097/00004872-199715020-00001 · External reference
10.1038/sj.jhh.1000518
10.1038/sj.jhh.1000518 · External reference
10.1111/j.1472-8206.1995.tb00508.x
10.1111/j.1472-8206.1995.tb00508.x · External reference
Sympathetic nervous control of blood pressure: role in primary hypertension
10.1093/ajh/2.3.103s · 1989 · External reference
10.1152/ajpregu.1997.273.5.r1572
10.1152/ajpregu.1997.273.5.r1572 · External reference
10.1152/ajpregu.1997.273.5.r1580
10.1152/ajpregu.1997.273.5.r1580 · External reference
10.1056/nejm199602083340607
10.1056/nejm199602083340607 · External reference
10.1111/j.1440-1681.1998.tb02148.x
10.1111/j.1440-1681.1998.tb02148.x · External reference
10.1097/00004872-199405000-00001
10.1097/00004872-199405000-00001 · External reference
Mechanism of antihyperglycemic effects of moxonidine in the obese spontaneously hypertensive Koletsky rat (SHROB)
10.1016/s0022-3565(24)37935-2 · 1999 · External reference
10.1161/01.hyp.30.6.1560
10.1161/01.hyp.30.6.1560 · External reference
Experimental benefit of moxonidine on glucose metabolism and insulin secretion in the fructose‐fed rat
10.1097/00004872-199715011-00004 · 1997 · External reference
Rilmenidine normalizes fructose‐induced insulin resistance and hypertension in rats
1998 · External reference
10.1111/j.2042-7158.1989.tb06474.x
10.1111/j.2042-7158.1989.tb06474.x · External reference
10.1111/j.2042-7158.1997.tb06036.x
10.1111/j.2042-7158.1997.tb06036.x · External reference
10.1161/01.hyp.10.5.512
10.1161/01.hyp.10.5.512 · External reference
10.1161/01.hyp.33.1.548
10.1161/01.hyp.33.1.548 · External reference
Effects of agmatine and moxonidine on glucose metabolism: an integrated approach towards pathophysiological mechanisms in cardiovascular metabolic disorders
1995 · External reference
10.1016/0002-9149(88)90473-0
10.1016/0002-9149(88)90473-0 · External reference
Acute metabolic effects of clonidine and adenosine in man
10.1055/s-2007-1002050 · 1993 · External reference
10.1097/00000542-199804000-00011
10.1097/00000542-199804000-00011 · External reference
Lipoproteins and metabolic control in hypertensive type II diabetics treated with clonidine
10.1111/j.0954-6820.1988.tb16750.x · 1988 · External reference
10.1016/s0895-7061(97)00319-1
10.1016/s0895-7061(97)00319-1 · External reference
1999 World Health Organization‐International Society of Hypertension Guidelines for the Management of Hypertension
1999 · External reference
10.1016/0014-2999(95)00455-t
10.1016/0014-2999(95)00455-t · External reference
